Merck (MRK) operating cash flow was $16.5B in FY2025 (-23% YoY). The tables below show the complete quarterly and annual operating cash flow history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Operating Cash Flow
Fiscal Year
Operating Cash Flow
YoY
2025
$16.5B
-23%
2024
$21.5B
+65%
2023
$13.0B
-32%
2022
$19.1B
+86%
2020
$10.3B
-24%
2019
$13.4B
+23%
2018
$10.9B
+69%
2017
$6.5B
-38%
2016
$10.4B
-17%
2015
$12.5B
+57%
2014
$8.0B
-31%
2013
$11.7B
+16%
2012
$10.0B
-19%
2011
$12.4B
+14%
2010
$10.8B
+219%
2009
$3.4B
-48%
2008
$6.6B
-6%
2007
$7.0B
Recent Quarterly Operating Cash Flow
Quarter
Operating Cash Flow
Q1 2026
$3.9B
Q4 2025
$2.9B
Q3 2025
$7.8B
Q2 2025
$3.3B
Q1 2025
$2.5B
Q4 2024
$3.5B
Q3 2024
$9.3B
Q2 2024
$5.6B
Q1 2024
$3.1B
Q4 2023
$246M
Q3 2023
$7.7B
Q2 2023
$3.7B
Source: MRK on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.